Treatments Available for High Risk Smoldering Myeloma Patients

Event Description
Join with us to learn the answers to the following questions with myeloma specialist Dr. Manasanch.
- What constitutes high-risk smoldering myeloma?
- What treatments are available to these patients?
- What are the risks of treating too early?
- Do you recommend clinical trials to all of your high risk SMM patients?
- Will the future always be watch and wait?
Schedule & Agenda

Audrey introduces the agenda of the event and featured speaker Elisabet E. Manasanch, M.D.

Audrey introduces the agenda of the event and featured speaker Elisabet E. Manasanch, M.D.

Dr. Manasanch talks about treatments for Smoldering Myeloma.

Dr. Manasanch talks about treatments for Smoldering Myeloma.
Type your questions in the chat and we will answer them!
Type your questions in the chat and we will answer them!
Speakers & Moderators

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Dr. Manasanch specializes in the treatment of patients with multiple myeloma. Furthermore, she focuses on translational research of the precursor stages of myeloma and early disease management through groundbreaking immunotherapy-focused clinical trials.
Join the Conversation
This event is part of the Watch and Wait group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org







Get the Latest Multiple Myeloma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.